Area:
Synaptic Plasticity, Alzheimer's Disease, NMDA receptors
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Brooke L. Sinnen is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2017 — 2018 |
Sinnen, Brooke |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Mechanisms of Beta Amyloid-Induced Synaptic Dysfunction @ University of Colorado Denver
Project Summary Alzheimer?s Disease (AD) is a prevalent neurodegenerative disease and the leading cause of age- related dementia. While the pathologic agent that causes AD remains controversial (A? vs. Tau) strong genetic, biochemical, anatomical and electrophysiological evidence have established that A? causes significant synapse loss and blocks induction of long-term potentiation (LTP), a form of plasticity critical for learning and memory. Soluble A? oligomers bind directly to excitatory synapses, but a significant fraction (~30- 40%) of synapses remain unbound. Correspondingly, a subset of synapses are spared from A?-triggered elimination, but the relationship between A? binding and elimination remains a fundamental question. Intriguingly, A?-mediated synapse loss requires activation of NMDA-type glutamate receptors (NMDARs), which gate Ca2+, a key second messenger for important forms of synaptic plasticity, including LTP. While pharmacologically blocking NMDARs prevents A?-induced synapse loss (suggesting that A? induces a gain of NMDAR function), A? also potently blocks LTP, suggesting that A? impairs NMDAR function, or downstream NMDAR signaling. Together, these results provide compelling evidence that NMDARs are a central mediator of A?-induced synaptotoxicity, yet there is a major gap in our understanding of how or whether A? influences NMDAR function. Furthermore, whether local synaptic activity plays a role in A? binding to synapses and whether only those synapses bound by A? are eventually eliminated remain fundamental questions. I will use a novel live cell imaging technique to assess changes in NMDAR function in response to A? at individual synaptic sites.
|
0.915 |